Benzaclin and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Benzaclin (benzoyl peroxide; clindamycin phosphate), especially for people who are female, 10-19 old, also take Paxil, and have Pain.

The phase IV clinical study analyzes which people have Weakness when taking Benzaclin. It is created by eHealthMe based on reports of 447 people who have side effects when taking Benzaclin from the FDA, and is updated regularly.

What is Benzaclin?

Benzaclin has active ingredients of benzoyl peroxide; clindamycin phosphate. It is often used in acne. eHealthMe is studying from 477 Benzaclin users. Check the latest studies of Benzaclin.

What is Weakness?

Weakness is found to be associated with 3,642 drugs and 6,611 conditions by eHealthMe. Check the latest studies of Weakness.

On May, 01, 2026

447 people reported to have side effects when taking Benzaclin.
Among them, 18 people (4.03%) have Weakness.

Among these 18 people:

What is the gender of people who have Weakness when taking Benzaclin? *

female: 58.82 %
male: 41.18 %

What is the age of people who have Weakness when taking Benzaclin? *

What are other drugs people take besides Benzaclin? *

What are other side effects people have besides Weakness? *

Nausea (feeling of having an urge to vomit): 8 people, 44.44%
Insomnia (sleeplessness): 7 people, 38.89%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 6 people, 33.33%
Dizziness: 6 people, 33.33%
Gastric Ulcer (stomach ulcer): 6 people, 33.33%
Fatigue (feeling of tiredness): 6 people, 33.33%
Nausea And Vomiting: 5 people, 27.78%
Hyperhidrosis (abnormally increased sweating): 5 people, 27.78%
Weight Decreased: 5 people, 27.78%
Headache (pain in head): 5 people, 27.78%

What are the existing conditions these people have? *

Stress And Anxiety: 3 people, 16.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 16.67%
Bacterial Infection: 3 people, 16.67%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 16.67%
Dysthymia (mild chronic depression): 3 people, 16.67%
Fatigue (feeling of tiredness): 3 people, 16.67%
Gastric Ph Decreased: 3 people, 16.67%
Pain: 3 people, 16.67%
Insomnia (sleeplessness): 2 people, 11.11%
Joint Pain: 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Benzaclin and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Benzaclin:

Benzaclin (477 reports)

Weakness treatments and more:

Weakness (586,876 reports)

How severe was Weakness and when was it recovered:

Weakness in Benzaclin

Expand to all the drugs that have ingredients of benzoyl peroxide; clindamycin phosphate:

Weakness and drugs with ingredients of benzoyl peroxide; clindamycin phosphate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Benzaclin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,642 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,611 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on benzoyl peroxide; clindamycin phosphate (the active ingredients of Benzaclin) and Benzaclin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.